-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Neumora Therapeutics, Maintains $5 Price Target

Benzinga·04/10/2025 10:15:15
Listen to the news
Needham analyst Ami Fadia reiterates Neumora Therapeutics (NASDAQ:NMRA) with a Buy and maintains $5 price target.